{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:54:44Z","timestamp":1776354884482,"version":"3.51.2"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Butler Hospital, Providence, RI"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.parkreldis.2020.08.031","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:49:45Z","timestamp":1598417385000},"page":"60-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Movement disorders induced by psychiatric drugs that do not block dopamine receptors"],"prefix":"10.1016","volume":"79","author":[{"given":"Joseph H.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.parkreldis.2020.08.031_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.psc.2016.04.003","article-title":"Drug induced extrapyramidal syndromes: implications for clinical practice","volume":"39","author":"Caroff","year":"2016","journal-title":"Psychiatr. Clin. North America"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2020.08.031_bib2","first-page":"108","article-title":"Acute and subacute drug induced movement disorders","volume":"29","author":"Burkhard","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib3","unstructured":"Friedman JH. Tardive syndromes. Continuum (Minneap Minn). [in Press]."},{"issue":"11","key":"10.1016\/j.parkreldis.2020.08.031_bib4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"Serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib5","series-title":"Medlink Neurology","article-title":"Serotonin syndrome","author":"Jain","year":"2019"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib6","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMicm1506066","article-title":"Ocular flutter in the serotonin syndrome","volume":"375","author":"Sim","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.parkreldis.2020.08.031_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(03)00439-3","article-title":"Convulsive ergotism: epidemics of the serotonin syndrome","volume":"2","author":"Eadie","year":"2003","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2020.08.031_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib9","series-title":"Serotonin Syndrome (serotonin toxicity)","author":"Boyer","year":"2019"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib10","series-title":"Father's grief, a father's fight: litigation","author":"Collins","year":"1995"},{"issue":"1","key":"10.1016\/j.parkreldis.2020.08.031_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-0038-1677050","article-title":"Movement disorders emergencies","volume":"39","author":"Rajan","year":"2019","journal-title":"Semin. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.08.031_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jcpt.12796","article-title":"An 11 year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System","volume":"44","author":"Nguyen","year":"2019","journal-title":"J. Clin. Pharm. Therapeut."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A Clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-016-0341-8","article-title":"Valproate-associated parkinsonism: a critical review of the literature","volume":"30","author":"Brugger","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib15","article-title":"Valproate induced rest tremor and parkinsonism","author":"Baizabal-Carvallo","year":"2019","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib16","series-title":"Medication Induced Movement Disorders","first-page":"131","article-title":"VPA, lithium, amiodarone, and other non-DA","author":"Silver","year":"2015"},{"issue":"8","key":"10.1016\/j.parkreldis.2020.08.031_bib17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/cells8080872","article-title":"Molecular imaging of the dopamine transporter","volume":"8","author":"Palermo","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2018.04.037","article-title":"DAT-SPECT imaging in cases of drug-induce parkinsonism in a specialty movement disorders practice","volume":"53","author":"Yomtoob","year":"2018","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2020.08.031_bib19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.47.3.626","article-title":"Reversible parkinsonism and cognitive impairment and chronic valproate use","volume":"47","author":"Armon","year":"1996","journal-title":"Neurol."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-2006-931471","article-title":"Parkinsonism and\/or cognitive impairment with valproic acid therapy: a report of 10 cases","volume":"39","author":"Masmoudi","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib21","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/j.1528-1167.2006.00711.x","article-title":"The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy","volume":"47","author":"Ristic","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.parkreldis.2020.08.031_bib22","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/ana.410150224","article-title":"Lithium and parkinsonism","volume":"15","author":"Lang","year":"1984","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2020.08.031_bib23","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1017\/S1041610216001101","article-title":"A case of lithium induced parkinsonism with typical motor symptoms of Parkinson's disease in a bipolar patient","volume":"28","author":"Hermida","year":"2016","journal-title":"Int. Psychogeriatr."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.08.031_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/089198879500800208","article-title":"Disabling parkinsonism due to lithium: a case report","volume":"8","author":"Holroyd","year":"1995","journal-title":"J. Geriatr. Psychiatr. Neurol."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib25","doi-asserted-by":"crossref","unstructured":"van Gerpen JA. Drug induced parkinsonism. Neurol.;8(6):363-370.","DOI":"10.1097\/00127893-200211000-00006"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib26","doi-asserted-by":"crossref","unstructured":"Montastruc JL, Llau ME, Rascol O, Senard M. Drug induced parkinsonism: a review. Fund. Clin. Pharmacol.;8(4):293-306.","DOI":"10.1111\/j.1472-8206.1994.tb00808.x"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jagp.2015.11.004","article-title":"Lithiu use in older adults is associated with increased prescribing of Parkinson medications","volume":"24","author":"Marras","year":"2016","journal-title":"Am. J. Geriatr. Psychiatr."},{"issue":"12","key":"10.1016\/j.parkreldis.2020.08.031_bib28","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/mds.23828","article-title":"Drug induced parkinsonism: a review of 17 years experience in a regional pharmaco-vigilance center in France","volume":"26","author":"Bondon-Guitton","year":"2011","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2020.08.031_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/WNF.0000000000000278","article-title":"Trazodone and parkinsonism","volume":"41","author":"Sarwar","year":"2018","journal-title":"Clin. Neuropharm."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.08.031_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004714-199710000-00007","article-title":"Extrapyramidal symptoms associated with cyclic anti-depressant treatment: a review of the literature and consolidating hypotheses","volume":"17","author":"Gil","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.parkreldis.2020.08.031_bib31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/1060028015594812","article-title":"Extrapyramidal reactions associated with serotonergic antidepressants","volume":"49","author":"Hawthorne","year":"2015","journal-title":"Ann. Pharacother."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.08.031_bib32","first-page":"278","article-title":"Does fluoxetine exacerbate Parkinson's disease?","volume":"53","author":"Caley","year":"1992","journal-title":"J. Clin. Pharmacol."},{"issue":"16","key":"10.1016\/j.parkreldis.2020.08.031_bib33","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","article-title":"A randomized double blind placebo controlled trial of antidepressants in Parkinson's disease","volume":"78","author":"Richard","year":"2012","journal-title":"Neurol."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib34","series-title":"Medication Induced Movement Disorders","first-page":"104","article-title":"Tremors","author":"Lewitt","year":"2015"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1440-1819.2008.01877.x","article-title":"Postural induced-tremor in psychiatry","volume":"62","author":"Arbaizar","year":"2008","journal-title":"Psychiatr. Clin. Neurosci."},{"issue":"3 Sec 2","key":"10.1016\/j.parkreldis.2020.08.031_bib36","first-page":"59","article-title":"The side effect profile and safety of fluoxetine","volume":"46","author":"Wernicke","year":"1985","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.parkreldis.2017.09.011","article-title":"The clinical features and functional impact of valproate-induced tremor","volume":"44","author":"Alonso-Juarez","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1212\/WNL.32.4.428","article-title":"Valproate tremors","volume":"32","author":"Karas","year":"1982","journal-title":"Neurol."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib39","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1474-4422(05)70250-7","article-title":"Drug-induced tremors","volume":"4","author":"Morgan","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2165\/00003495-199957040-00005","article-title":"Systematic review and guide to selection of selective serotonin reuptake inhibitors","volume":"57","author":"Edwards","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-0327(98)00224-9","article-title":"Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression","volume":"51","author":"Fawcett","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-0-444-64189-2.00022-6","article-title":"Toxic induced cerebellar syndromes from the fetal period to the elderly","volume":"155","author":"Manto","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib43","series-title":"Medication Induced Movement Disorders","first-page":"pp150","article-title":"Ataxia","author":"Abraham","year":"2015"},{"issue":"12","key":"10.1016\/j.parkreldis.2020.08.031_bib44","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s40263-014-0200-4","article-title":"Drug induced cerebellar ataxia: a systematic review","volume":"28","author":"van Gaalen","year":"2014","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.parkreldis.2020.08.031_bib45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.psym.2013.11.007","article-title":"Lithium induced neurotoxicity","volume":"55","author":"Ivkovic","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib46","article-title":"Restless legs syndrome","author":"Agarwal","year":"2019","journal-title":"Medlink"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.smrv.2017.06.002","article-title":"The influence of antidepressants on restless legs syndrome and periodic limb movements: a systematic review","volume":"38","author":"Kolla","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib48","series-title":"Medication Induced Movement Disorders","first-page":"160","article-title":"Myoclonus and asterixis","author":"Thompson","year":"2015"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pnpbp.2009.10.006","article-title":"Clozapine induced myoclonus: a case study and review","volume":"34","author":"Praha raj","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psych."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4088\/JCP.v57n1002","article-title":"Movement disorder side effects associated with the selective serotonin reuptake inhibitors","volume":"57","author":"Leo","year":"1996","journal-title":"J. Clin. Psychiatr."},{"issue":"9","key":"10.1016\/j.parkreldis.2020.08.031_bib51","first-page":"339","article-title":"Fluoxetine induced akathisia: clinical and theoretical implications","volume":"50","author":"Lipinski","year":"1989","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib52","series-title":"Medication Induced Movement Disorders","first-page":"3","article-title":"Acute akathisia","author":"Kern","year":"2015"},{"issue":"2","key":"10.1016\/j.parkreldis.2020.08.031_bib53","first-page":"50","article-title":"Antidepressant induced activation in children and adolescents: risk, recognition and management","volume":"48","author":"Luft","year":"2018","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"issue":"11","key":"10.1016\/j.parkreldis.2020.08.031_bib54","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.mayocp.2017.09.007","article-title":"REM sleep behavior disorder. Medlink 2019St. Louis EK, Boeve BF. REM sleep behavior disorder: diagnosis, clinical implications and future directions","volume":"92","author":"McCarter","year":"2017","journal-title":"Mayo Clin. Proc."},{"issue":"11","key":"10.1016\/j.parkreldis.2020.08.031_bib55","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.5665\/sleep.3102","article-title":"Antidepressants and REM sleep behavior disorder: related side effect or neuro-degenerative signal?","volume":"36","author":"Postuma","year":"2013","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.parkreldis.2020.08.031_bib56","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1212\/WNL.0000000000001215","article-title":"Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression","volume":"84","author":"Wing","year":"2015","journal-title":"Neurol."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib57","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.smrv.2016.11.002","article-title":"Idiopathic REM sleep behavior disorder and neuro-degenerative risk: to tell or not to tell the patient. How to minimize the risk?","volume":"36","author":"Arnaldi","year":"2017","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.parkreldis.2020.08.031_bib58","series-title":"Diagnostic and Statistical Manual on Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.parkreldis.2020.08.031_bib59","doi-asserted-by":"crossref","first-page":"570","DOI":"10.5334\/tohm.438","article-title":"Tardive dyskinesia-like syndrome due to drugs that do not block dopamine receptors: rare or nonexistent. Literature Review","volume":"8","author":"D'Abreu","year":"2018","journal-title":"Tremor and Other Hyperkinetic Movement Dis (NY)"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020306970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020306970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:47:13Z","timestamp":1774860433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020306970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":59,"alternative-id":["S1353802020306970"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.08.031","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Movement disorders induced by psychiatric drugs that do not block dopamine receptors","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}